Skip to main content

Table 6 Anthropometric measurements (ITT) at different control times (T1 baseline and, T5, T9, T13) in groups treated with PG and O

From: Randomised, double-blind, clinical investigation to compare orlistat 60 milligram and a customized polyglucosamine, two treatment methods for the management of overweight and obesity

Variable

Group

T1

T1 - T5

T1 - T9

T1 - T13

Weight (kg)

polyglucosamine

100.6 ± 13.22

3.36 ± 2.66

4.98 ± 2.90#

6.24 ± 3.46*

orlistat

98.2 ± 11.47

2.73 ± 1.48

3.32 ± 1.77

4.63 ± 2.36

BMI (kg/m2)

polyglucosamine

34.6 ± 3.70

1.13 ± 0.88

1.71 ± 0.99*

2.15 ± 1.21

orlistat

34.8 ± 4.73

0.97 ± 0.54

1.20 ± 0.67

1.66 ± 0.90

WC (cm)

polyglucosamine

112.4 ± 10.95

3.22 ± 3.29

5.06 ± 4.56

7.34 ± 4.83

orlistat

110.0 ± 10.38

2.53 ± 2.65

5.12 ± 2.60

5.91 ± 3.54

  1. #p <0.01, *p < 0.05